【摘要】 目的　将经肝动脉化疗栓塞 (TACE)和经门静脉植入化疗药盒持续灌注化疗药 (VPC) 2种方法结合 ,观察原发性肝癌(HCC)经肝动脉化疗栓塞和经门静脉植入化疗药盒持续灌注化疗药的疗效。方法　对照组 83例中晚期患者 ,用表柔比星 (EPI) 40mg和顺铂 (CDDP) 80mg与碘化油配制成碘油———化疗药物乳化剂 ,经导管向肝癌供血动脉注入 ,后用明胶海绵 (GS)颗粒栓塞该动脉。治疗组 5 9例中晚期HCC患者 ,用上述方法治疗后 ,再经皮下埋置式药盒经门静脉定期灌注化疗药。结果　对照组与治疗组有效率 (完全缓解 +部分缓解 )分别为 45 .8%和 61.0 % (P <0 .0 5 ) ,2组治疗后Ⅱ期手术切除率分别为 3 .6%和 11.9% (P <0 .0 5 )。对照组 1年、2年、3年生存率分别为 69.9%、60 .2 %和 2 0 .5 % ;治疗组分别为 96.6%、67.8%和 42 .4% (P <0 .0 5 )。并发症差异无显著性意义。结论　经肝动脉化疗栓塞和经门静脉植入化疗药盒持续灌注化疗药是治疗原发性肝癌的较好方法 ,能提高疗效更多还原

【Abstract】 Objective To study the efficacy of transcatheter arterial chemoembolization (TACE )and continuous portal vein perfusion chemothepary (VPC) on advanced hepatocellular carcinoma cells (HCC). Methods The patients in group A (n=83) received the epirubicin (EPI) 40 mg and the cisplatin (CDDP) 80mg, lipiodol-anticancer drug emulsion was injected into the feeding arteries of tumors followed by embolization with gelatin sponge (GS) particles. Patients in group B (n=59) after receiving the same as the group A then VPC was carried out. Results The response rate ( CR + PR) in group A and B was 45.8% and 61.0%(P<0.05)respectively; the secondary respectable rate was 3.6% and 11.9% in group A and group B (P<0.05)respectively. The survival rate for 1,2 and 3 gears in group A was 69.9%、60.2% and 20.5% respectively ;in group B was 96.6%,67.8% and 42.4% (P<0.05)respectively. However.There was no marked difference in the incidente rate of complications between the two groups.Conclusion The therapeutic effect of TACE and VPC on HCC is better than that of TACE alone.更多还原